- Home
- / Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals
Stock Price
$20
2024-10-29
Market Capitalization
$2.5 B
2024-10-29
Revenue
$829.4 M
FY, 2025
Arrowhead Pharmaceuticals Summary
Company Summary
- Overview
- Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development. It discovers and delivers therapies and medicines for chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and asthma.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- Pasadena, CA, US | view all locations
- Website
- https://arrowheadpharma.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
James Hamilton, Senior Vice President, Discovery and Translational Medicine
Patrick O'Brien, General Counsel, Corporate Secretary, and Chief Compliance Officer
Ken Myszkowski, Chief Financial Officer
Operating MetricsView all
Pre-Clinical Phase Products
6
FY, 2016
Patent Applications
256
FY, 2016
Facilities
2
FY, 2016
LocationsView all
3 locations detected
Pasadena, CA HQ
United States
177 East Colorado Boulevard, Suite 700
Madison, WI
United States
502 S Rosa Rd
San Diego, CA
United States
11404 Sorrento Valley Rd
Arrowhead Pharmaceuticals Financials
Summary Financials
- Revenue (Q2, 2026)
- $73.7M
- Net income (Q2, 2026)
- ($137.6M)
- Cash (Q2, 2026)
- $161.0M
- EBIT (Q2, 2026)
- ($141.3M)
- Enterprise value
- $3.3B